Mounjaro (tirzepatide) is a prescription medication that is used to treat type 2 diabetes and to promote weight loss in adults with obesity or overweight. It is a dual agonist, meaning that it works by activating two different receptors in the body: glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).
GLP-1 and GIP are hormones that help to regulate blood sugar levels and appetite. By activating these receptors, Mounjaro helps to lower blood sugar levels, increase satiety, and reduce food intake. This can lead to significant weight loss over time.
In clinical trials, people who took Mounjaro for weight loss lost an average of 15-20% of their body weight over 64 weeks. This was significantly more weight loss than people who took other weight loss medications, such as semaglutide (Ozempic, Wegovy).
Mounjaro is given as an injection once per week. It is generally safe and well-tolerated, but it can cause some side effects, such as nausea, vomiting, diarrhea, and abdominal pain.
Mounjaro is a new medication, and it is not yet known how long it is safe and effective to take for weight loss. However, it is a promising new option for people who are struggling to lose weight with diet and exercise alone.
If you are considering taking Mounjaro for weight loss, it is important to talk to your doctor about the risks and benefits. Mounjaro is not right for everyone, and it is important to make sure that it is safe for you to take.